Melissa Kate Accordino, MD, MS
Division of Hematology/Oncology
Dr. Accordino graduated from The Pennsylvania State University with a bachelor of science in Premedicine with minors in Health Policy and Administration and Biology. She completed her medical degree at The Pennsylvania State University College of Medicine. While in medical school she was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. She completed her Internal Medicine residency at Weill Cornell Medical Center and her Medical Hematology/Oncology fellowship at Columbia University Medical Center, where she served as Chief Fellow. During that time she was awarded a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award and Merit Award. She also served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in quality improvement and health outcomes research. Upon fellowship graduation she became an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University. Dr. Accordino is currently involved in patient care, clinical research, education, and quality improvement.
Dr. Accordino’s research involves improving the quality and delivery of cancer care, and cancer survivorship. Dr. Accordino participates in clinical trials at the local and national level, and participates in multicenter cancer trials through SWOG. The overall goal of this research is to improve quality and outcomes within oncology.
- Breast Cancer
- Hematologic/ Blood Cancers
Alpha Omega Alpha, The Pennsylvania State University
Conquer Cancer Foundation of The American Society of Clinical Oncology (ASCO) Young Investigator Award
Conquer Cancer Foundation of The American Society of Clinical Oncology (ASCO) Merit Award
SWOG Leadership Academy
Accordino MK, Wright JD, Vasan S, Neugut AI, Hillyer G, Hu JC, Hershman DL. Use and Costs of Disease Monitoring in Women with Metastatic Breast Cancer. Journal of Clinical Oncology 2016; 34(24):2820-6
Accordino, MK, Wright JD, Vasan S, Neugut AI, Hillyer GC, Hershman DL. Factors and Costs Associated with Delay in Treatment Initiation and Prolonged Length of Stay with Inpatient EPOCH Chemotherapy in Patients with Hematologic Malignancies. Cancer Investigation; 2017:35(3):202-2014.
Yang J, Neugut AI, Wright JD, Accordino M, Hershman DL. Nonadherence to oral medications for chronic conditions in breast cancer survivors. Journal of Oncology Practice 2016;12(8):e800-9.
Neugut AI, Zhong X, Wright JD, Accordino MK, Yang J, Hershman DL. Nonadherence to medications for chronic conditions and nonadherence to adjuvant hormonal therapy in women with breast cancer. JAMA Oncology [E pub ahead of print Jun 9, 2016].
Wright JD, Chen L, Tergas AI, Accordino MK, Anath CV, Neugut AI, Hershman DL. Underuse of BRCA testing in patients with breast and ovarian cancer. American Journal of Obstetrics and Gynecology 2016;214(6):761-3
Accordino, MK, Wright JD, Vasan S, Neugut AI, Tergas AI, Hu JC, Hershman DL. Serum Tumor Marker Utilization in Patients with Advanced Solid Tumors. Journal of Oncology Practice 2016:12(1):65-6.
Accordino MK, Wright JD, Buono D, Neugut AI, Hershman DL. Trends in use and safety of image-guided transthoracic needle biopsies in cancer patients. Journal of Oncology Practice 2015;11(3):e351-359.
Accordino MK, Neugut AI, Hershman DL. Cardiac Effects of Anticancer Therapy in the Elderly. Journal of Clinical Oncology 2014;32(24):2662-8.
Accordino MK, Hershman DL. Disparities and challenges in adherence to oral antineoplastic agents. American Society of Clinical Oncology Educational Book 2013;2013:271-6.